FGFR1OP2 Polyclonal Antibody, PE-Cy5.5 Conjugated
Applications
Predicted Reactivity
| Overview | |
| Catalog # | bs-8346R-PE-Cy5.5-100uL |
| Product Name | FGFR1OP2 Polyclonal Antibody, PE-Cy5.5 Conjugated |
| Applications |
WB
|
| Predicted Reactivity | Human, Mouse, Rat, Dog, Horse, Rabbit |
| Specifications | |
| Conjugation | PE-Cy5.5 |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human FGFR1OP2 |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 26127 |
| Subcellular location | Cytoplasm |
| Synonyms | DKFZp564O1863; FGFR1 oncogene partner 2; HSPC123; HSPC123 like; FGOP2_HUMAN. |
| Background | FGFR1OP2 belongs to the SIKE family. The FGFR1OP2 (FGFR1 oncogene partner 2) gene was identified through its involvement in a fusion with the FGFR1 gene. FGFR1OP2 may be involved in the wound healing pathway. It is expressed in bone marrow, spleen and thymus. A chromosomal aberration involving FGFR1OP2 may be a cause of stem cell myeloproliferative disorder (MPD). Insertion ins(12;8)(p11;p11p22) with FGFR1. MPD is characterized by myeloid hyperplasia, eosinophilia and T cell or B cell lymphoblastic lymphoma. In general it progresses to acute myeloid leukemia. The fusion protein FGFR1OP2-FGFR1 may exhibit constitutive kinase activity and be responsible for the transforming activity. |
| Application Dilution | |
| WB | 1:300-5000 |
Frequently asked questions
Which applications is FGFR1OP2 Polyclonal Antibody, PE-Cy5.5 Conjugated (BS-8346R-PE-CY5-5) validated for, and at what dilution?
BS-8346R-PE-CY5-5 is validated for WB (1:300-5000). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
How should BS-8346R-PE-CY5-5 be stored?
Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise FGFR1OP2 Polyclonal Antibody, PE-Cy5.5 Conjugated (BS-8346R-PE-CY5-5)?
KLH conjugated synthetic peptide derived from human FGFR1OP2
What are the excitation and emission wavelengths of the PE-Cy5.5 conjugate (BS-8346R-PE-CY5-5)?
PE-Cy5.5 on BS-8346R-PE-CY5-5: excitation / emission 488nm/694nm.